Employees: 02 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2018-01-01 (8 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: ROUBAIX (59100), Nord
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE JULIE GRAVE : revenue, balance sheet and financial ratios
PHARMACIE JULIE GRAVE is a French company
founded 8 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ROUBAIX (59100),
this company of category PME
shows in 2025 a net income positive of 85 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE JULIE GRAVE (SIREN 833373434)
Indicator
2025
2024
2023
2022
2021
2020
2019
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
85 477 €
98 014 €
106 306 €
130 608 €
144 383 €
115 599 €
182 228 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE JULIE GRAVE generates positive net income of 85 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2025: 182 k€ -> 85 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
85 477 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 64%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 54%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
63.648%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
54.103%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
2024
2025
Debt ratio
473.075
293.046
196.951
151.385
127.508
99.243
63.648
Financial autonomy
15.482
22.79
29.913
34.347
39.851
45.433
54.103
Repayment capacity
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
63.652025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average-10 pts over 3 years
In 2025, the debt ratio of PHARMACIE JULIE GRAVE (63.65) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
54.1%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Good+11 pts over 3 years
In 2025, the financial autonomy of PHARMACIE JULIE GRAVE (54.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 231.30. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
206.797
210.481
232.977
234.968
348.51
339.239
231.303
Interest coverage
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
231.32025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Good-9 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE JULIE GRAVE (231.30) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE JULIE GRAVE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE JULIE GRAVE is estimated at
1 357 812 €
(range 921 417€ - 2 130 594€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
921k€1357k€2130k€
1 357 812 €Range: 921 417€ - 2 130 594€
NAF 5 année 2025
Valuation method used
Net Income Multiple
85 477 €
×
15.9x
=1 357 812 €
Range: 921 418€ - 2 130 594€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE JULIE GRAVE with other companies in the same sector:
Frequently asked questions about PHARMACIE JULIE GRAVE
What is the revenue of PHARMACIE JULIE GRAVE ?
The revenue of PHARMACIE JULIE GRAVE is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE JULIE GRAVE profitable?
Yes, PHARMACIE JULIE GRAVE generated a net profit of 85 k€ in 2025.
Where is the headquarters of PHARMACIE JULIE GRAVE ?
The headquarters of PHARMACIE JULIE GRAVE is located in ROUBAIX (59100), in the department Nord.
Where to find the tax return of PHARMACIE JULIE GRAVE ?
The tax return of PHARMACIE JULIE GRAVE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE JULIE GRAVE operate?
PHARMACIE JULIE GRAVE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart